Tag:
bosutinib
Latest Headlines
Latest Headlines
Pfizer's bosutinib fails head-to-head showdown with Gleevec
With investors still digesting the news of Jeff Kindler's quick exit, Pfizer ( $PFE ) had yet another pivotal trial failure on its hands. This time around the bad news was about bosutinib, a cancer
